UBS Group’s Xenetic Biosciences XBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,531
Closed -$6.61K 9392
2025
Q1
$6.61K Buy
2,531
+875
+53% +$2.28K ﹤0.01% 7573
2024
Q4
$6.61K Buy
+1,656
New +$6.61K ﹤0.01% 7306
2024
Q3
Sell
-182
Closed -$741 8810
2024
Q2
$741 Sell
182
-2,893
-94% -$11.8K ﹤0.01% 7621
2024
Q1
$11.6K Buy
3,075
+2,770
+908% +$10.4K ﹤0.01% 6002
2023
Q4
$1.05K Buy
+305
New +$1.05K ﹤0.01% 7204
2022
Q4
Sell
-786
Closed -$4K 9850
2022
Q3
$4K Buy
786
+694
+754% +$3.53K ﹤0.01% 8300
2022
Q2
$1K Buy
+92
New +$1K ﹤0.01% 8934
2022
Q1
Sell
-606
Closed -$8K 9663
2021
Q4
$8K Buy
606
+341
+129% +$4.5K ﹤0.01% 7940
2021
Q3
$5K Sell
265
-256
-49% -$4.83K ﹤0.01% 7415
2021
Q2
$11K Buy
521
+424
+437% +$8.95K ﹤0.01% 6882
2021
Q1
$2K Buy
+97
New +$2K ﹤0.01% 7609
2020
Q4
Sell
-940
Closed -$9K 7671
2020
Q3
$9K Buy
+940
New +$9K ﹤0.01% 6077
2020
Q1
Sell
-976
Closed -$14K 7264
2019
Q4
$14K Buy
976
+699
+252% +$10K ﹤0.01% 6031
2019
Q3
$3K Buy
277
+92
+50% +$996 ﹤0.01% 6695
2019
Q2
$21K Buy
185
+173
+1,442% +$19.6K ﹤0.01% 5709
2019
Q1
$3K Sell
12
-5
-29% -$1.25K ﹤0.01% 6514
2018
Q4
$3K Buy
+17
New +$3K ﹤0.01% 6805
2018
Q3
Hold
0
7198
2018
Q2
Sell
-22
Closed -$6K 7182
2018
Q1
$6K Sell
22
-9
-29% -$2.46K ﹤0.01% 6274
2017
Q4
$7K Buy
31
+15
+94% +$3.39K ﹤0.01% 6268
2017
Q3
$4K Buy
16
+12
+300% +$3K ﹤0.01% 6402
2017
Q2
$1K Buy
+4
New +$1K ﹤0.01% 6571
2017
Q1
Sell
-2
Closed -$1K 6845
2016
Q4
$1K Buy
+2
New +$1K ﹤0.01% 6647